Free Trial

Monte Rosa Therapeutics (GLUE) Institutional Ownership

Monte Rosa Therapeutics logo
$18.68 -0.28 (-1.48%)
Closing price 04:00 PM Eastern
Extended Trading
$18.68 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Monte Rosa Therapeutics (NASDAQ:GLUE)

Current
Institutional Ownership
Percentage
79.96%
Number of
Institutional Buyers
(last 12 months)
91
Total
Institutional Inflows
(last 12 months)
$175.45M
Number of
Institutional Sellers
(last 12 months)
32
Total
Institutional Outflows
(last 12 months)
$117.02M
Get GLUE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Monte Rosa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

GLUE Institutional Buying and Selling by Quarter

Monte Rosa Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Arrowstreet Capital Limited Partnership647,739$10.66M0.0%+110.5%0.767%
5/14/2026Sei Investments Co.77,681$1.28M0.0%+30.2%0.092%
5/14/2026State of Wyoming17,645$290K0.0%N/A0.021%
5/7/2026 Dimensional Fund Advisors LP1,041,372$17.13M0.0%+83.2%1.234%
5/7/2026 AlphaCentric Advisors LLC12,566$207K0.2%N/A0.015%
5/7/2026 Swiss National Bank61,100$1.01M0.0%N/A0.072%
5/6/2026 Allspring Global Investments Holdings LLC392,227$6.45M0.0%+1,355.1%0.465%
5/5/2026 Versant Venture Management LLC3,180,780$52.32M37.0%-27.4%3.770%
5/5/2026 Bank of New York Mellon Corp204,687$3.37M0.0%+18.1%0.243%
5/4/2026 Principal Financial Group Inc.42,391$697K0.0%N/A0.053%
4/25/2026 Strs Ohio42,700$702K0.0%+18.3%0.053%
4/22/2026 Sterling Capital Management LLC2,005$33K0.0%-78.9%0.003%
4/16/2026 SG Americas Securities LLC20,468$337K0.0%+18.5%0.026%
2/26/2026Seven Fleet Capital Management LP4,000$63K0.0%N/A0.006%
2/23/2026Virtu Financial LLC18,717$293K0.0%+56.6%0.029%
2/19/2026 Invesco Ltd.362,213$5.68M0.0%+270.0%0.556%
2/18/2026Mercer Global Advisors Inc. ADV10,971$172K0.0%N/A0.017%
2/18/2026Empowered Funds LLC278,077$4.36M0.0%+218.0%0.427%
2/18/2026XTX Topco Ltd31,125$488K0.0%-37.9%0.048%
2/18/2026Voloridge Investment Management LLC35,783$561K0.0%N/A0.055%
2/18/2026Vestal Point Capital LP775,000$12.15M0.4%-3.1%1.190%
2/18/2026Virtus Investment Advisers LLC16,310$256K0.1%-29.5%0.025%
2/18/2026Wellington Management Group LLP148,057$2.32M0.0%-6.6%0.227%
2/18/2026Millennium Management LLC103,972$1.63M0.0%-76.6%0.160%
2/18/2026Man Group plc16,312$256K0.0%-59.8%0.025%
2/18/2026Baker BROS. Advisors LP4,345,736$68.14M0.4%-11.6%6.673%
2/18/2026Bridgeway Capital Management LLC523,377$8.21M0.2%+45.8%0.804%
2/18/2026BVF Inc. IL3,835,886$60.15M2.0%-32.2%5.890%
2/17/2026AQR Capital Management LLC785,057$12.31M0.0%+9.5%1.206%
2/17/2026Braidwell LP948,316$14.87M0.5%N/A1.456%
2/17/2026MPM Bioimpact LLC1,173,376$18.40M2.1%N/A1.802%
2/17/2026Trexquant Investment LP149,712$2.35M0.0%N/A0.230%
2/17/2026Price T Rowe Associates Inc. MD5,118,904$80.27M0.0%+10.4%7.861%
2/17/2026Diadema Partners LP62,281$977K0.2%N/A0.096%
2/17/2026Atom Investors LP137,261$2.15M0.2%N/A0.211%
2/17/2026Royal Bank of Canada2,818$44K0.0%-99.4%0.004%
2/17/2026 Persistent Asset Partners Ltd22,211$348K0.2%N/A0.034%
2/16/2026Squarepoint Ops LLC10,029$157K0.0%-89.4%0.015%
2/16/2026Mariner LLC21,600$340K0.0%+56.9%0.033%
2/16/2026Barclays PLC135,984$2.13M0.0%+86.4%0.209%
Your book is inside (Ad)

The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel

2/13/2026Nantahala Capital Management LLC57,991$909K0.0%N/A0.089%
2/13/2026Marshall Wace LLP398,890$6.26M0.0%-55.8%0.613%
2/13/2026The Manufacturers Life Insurance Company 134,674$2.15M0.0%+13.8%0.207%
2/13/2026Advisory Research Inc.63,220$991K0.1%N/A0.097%
2/13/2026Rafferty Asset Management LLC67,438$1.06M0.0%N/A0.104%
2/13/2026Charles Schwab Investment Management Inc.448,714$7.04M0.0%+17.1%0.689%
2/13/2026 Police & Firemen s Retirement System of New Jersey12,417$195K0.0%-22.4%0.019%
2/13/2026State Street Corp2,107,480$33.05M0.0%+148.9%3.236%
2/13/2026Ieq Capital LLC89,268$1.40M0.0%+51.1%0.137%
2/13/2026Martingale Asset Management L P12,413$195K0.0%N/A0.019%
2/13/2026 Wells Fargo & Company MN52,588$825K0.0%+45.0%0.081%
2/13/2026 Alphabet Inc.744,948$11.68M0.5%-49.1%1.144%
2/12/2026 Versant Venture Management LLC4,382,687$68.72M45.5%-22.5%6.730%
2/12/2026MetLife Investment Management LLC26,187$411K0.0%+7.5%0.040%
2/12/2026 Dimensional Fund Advisors LP568,367$8.91M0.0%-10.1%0.873%
2/12/2026Informed Momentum Co LLC70,037$1.10M0.1%N/A0.108%
2/12/2026Campbell & CO Investment Adviser LLC90,752$1.42M0.1%+77.5%0.139%
2/12/2026 Nuveen LLC285,859$4.48M0.0%+177.6%0.439%
2/11/2026Empowered Funds LLC278,077$4.36M0.0%+218.0%0.427%
2/11/2026 Deutsche Bank AG33,108$519K0.0%+34.7%0.051%
2/11/2026Franklin Resources Inc.85,231$1.34M0.0%+96.3%0.131%
2/11/2026 Los Angeles Capital Management LLC26,806$420K0.0%-5.6%0.041%
2/11/2026 WINTON GROUP Ltd22,930$360K0.0%N/A0.035%
2/10/2026 TD Asset Management Inc213,464$3.35M0.0%+24.1%0.328%
2/10/2026Goldman Sachs Group Inc.295,878$4.64M0.0%+192.5%0.454%
2/10/2026AXQ Capital LP13,742$215K0.0%N/A0.021%
2/10/2026 Intech Investment Management LLC19,392$304K0.0%+44.7%0.030%
2/9/2026Geode Capital Management LLC1,204,844$18.90M0.0%+4.6%1.850%
2/6/2026 ProShare Advisors LLC11,374$178K0.0%+11.8%0.017%
2/5/2026 Baader Bank Aktiengesellschaft11,000$172K0.0%N/A0.017%
2/2/2026 Strs Ohio36,100$566K0.0%N/A0.055%
1/29/2026Vanguard Group Inc.3,246,500$50.91M0.0%+8.6%4.985%
1/29/2026 China Universal Asset Management Co. Ltd.18,611$292K0.0%-39.6%0.029%
1/26/2026 Mirae Asset Global Investments Co. Ltd.3,164$50K0.0%+32.5%0.005%
1/26/2026CWM LLC29,444$462K0.0%+13.6%0.045%
1/22/2026Massachusetts Financial Services Co. MA49,630$778K0.0%N/A0.076%
1/22/2026 Brookwood Investment Group LLC19,535$306K0.0%N/A0.030%
1/16/2026 Tema Etfs LLC24,767$388K0.0%N/A0.038%
1/15/2026 Nisa Investment Advisors LLC3,151$49K0.0%+16.7%0.005%
1/15/2026 Allspring Global Investments Holdings LLC26,955$423K0.0%+9.6%0.041%
1/13/2026 Mayflower Financial Advisors LLC10,000$157K0.0%N/A0.015%
1/9/2026 SG Americas Securities LLC17,279$271K0.0%N/A0.027%
1/8/2026 Wealth Enhancement Advisory Services LLC22,289$357K0.0%+20.2%0.034%
1/5/2026 GAMMA Investing LLC1,905$30K0.0%N/A0.003%
1/1/2026JPMorgan Chase & Co.22,939$170K0.0%-7.8%0.035%
11/17/2025Vestal Point Capital LP800,000$5.93M0.3%N/A1.229%
11/17/2025Scientech Research LLC16,254$120K0.0%N/A0.025%
11/17/2025Qube Research & Technologies Ltd147,726$1.10M0.0%-27.4%0.227%
11/17/2025Prelude Capital Management LLC10,202$76K0.0%N/A0.016%
11/17/2025Millennium Management LLC444,939$3.30M0.0%+588.4%0.683%
Read this warning immediately (Ad)

Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Read Porter Stansberry's full breakdown and protect your wealth now
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.21,265$158K0.0%-16.7%0.033%
11/17/2025Focus Partners Wealth11,724$87K0.0%-8.3%0.018%
11/17/2025Brevan Howard Capital Management LP46,912$348K0.0%+31.2%0.072%
11/17/2025Bank of America Corp DE269,643$2.00M0.0%-0.6%0.414%
11/14/2025Virtu Financial LLC11,952$89K0.0%N/A0.018%
11/14/2025Man Group plc40,575$301K0.0%+11.5%0.062%
11/14/2025ADAR1 Capital Management LLC215,752$1.60M0.2%N/A0.331%
11/14/2025Two Sigma Investments LP161,481$1.20M0.0%-32.7%0.248%
11/14/2025Bridgeway Capital Management LLC358,850$2.66M0.1%+32.2%0.551%
11/14/2025Squarepoint Ops LLC94,707$702K0.0%-46.8%0.145%


GLUE Institutional Ownership - Frequently Asked Questions

During the previous two years, 132 institutional investors and hedge funds held shares of Monte Rosa Therapeutics. The most heavily invested institutionals were Price T Rowe Associates Inc. MD ($80.27M), Baker BROS. Advisors LP ($68.14M), BVF Inc. IL ($60.15M), Versant Venture Management LLC ($52.32M), Vanguard Group Inc. ($50.91M), State Street Corp ($33.05M), and Avoro Capital Advisors LLC ($30.15M).Learn more on Monte Rosa Therapeutics' institutional investors.

79.96% of Monte Rosa Therapeutics' stock is owned by institutional investors. Learn more on GLUE's institutional investor holdings.

Of the 117 institutional investors that purchased Monte Rosa Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($5.66M), Versant Venture Management LLC ($5.65M), AQR Capital Management LLC ($1.35M), State Street Corp ($1.31M), MPM Bioimpact LLC ($1.17M), Price T Rowe Associates Inc. MD ($1.15M), and Braidwell LP ($948.32K).

Institutional investors have bought a total of 16,797,334 shares in the last 24 months. This purchase volume represents approximately $169.85M in transactions.

Of the 31 institutional investors that sold Monte Rosa Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Versant Venture Management LLC ($2.47M), BVF Inc. IL ($1.82M), Alphabet Inc. ($719.07K), Baker BROS. Advisors LP ($570.36K), Marshall Wace LLP ($503.94K), Royal Bank of Canada ($432.95K), and Millennium Management LLC ($340.97K).

Institutional investors have sold a total of 7,717,461 shares in the last 24 months. This volume of shares sold represents approximately $117.02M in transactions.



This page (NASDAQ:GLUE) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners